The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Research Report 2025

Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1718650

No of Pages : 94

Ask Your Query

Report Description
Table of Content

Synopsis
The global HIV Integrase Strand Transfer Inhibitors (INSTI) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for HIV Integrase Strand Transfer Inhibitors (INSTI) in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of HIV Integrase Strand Transfer Inhibitors (INSTI) include Adcock Ingram Limited, Affine Formulations Limited, Aurobindo Pharma, Biocon Limited, Bristol-Myers Squibb, Cipla, Emcure Pharmaceuticals, Flamingo Pharmaceuticals Limited and Gilead Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HIV Integrase Strand Transfer Inhibitors (INSTI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Integrase Strand Transfer Inhibitors (INSTI).
Report Scope
The HIV Integrase Strand Transfer Inhibitors (INSTI) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV Integrase Strand Transfer Inhibitors (INSTI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Integrase Strand Transfer Inhibitors (INSTI) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Limited
Bristol-Myers Squibb
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
IPCA Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
LAURUS Labs
Medisist Pharma
Merck
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)
Segment by Type
Raltegravir
Elvitegravir Combination Drugs
Dolutegravir and Its Combination Drug
Bictegravir Combination Drug
Cabotegravir
Others
Segment by Application
Hospital
Clinic
Drug Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Integrase Strand Transfer Inhibitors (INSTI) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Raltegravir
1.2.3 Elvitegravir Combination Drugs
1.2.4 Dolutegravir and Its Combination Drug
1.2.5 Bictegravir Combination Drug
1.2.6 Cabotegravir
1.2.7 Others
1.3 Market by Application
1.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Perspective (2019-2030)
2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Growth Trends by Region
2.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Region (2019-2024)
2.2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Region (2025-2030)
2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Dynamics
2.3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Trends
2.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
2.3.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
2.3.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue
3.1.1 Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Revenue (2019-2024)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Players (2019-2024)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue
3.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio
3.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2023
3.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Area Served
3.6 Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
3.7 Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Type
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Type (2019-2024)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2025-2030)
5 HIV Integrase Strand Transfer Inhibitors (INSTI) Breakdown Data by Application
5.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Historic Market Size by Application (2019-2024)
5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2019-2030)
6.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024)
6.4 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2019-2030)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024)
7.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2019-2030)
8.2 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2019-2024)
8.4 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2019-2030)
9.2 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024)
9.4 Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2019-2030)
10.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024)
10.4 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adcock Ingram Limited
11.1.1 Adcock Ingram Limited Company Detail
11.1.2 Adcock Ingram Limited Business Overview
11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.1.4 Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.1.5 Adcock Ingram Limited Recent Development
11.2 Affine Formulations Limited
11.2.1 Affine Formulations Limited Company Detail
11.2.2 Affine Formulations Limited Business Overview
11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.2.4 Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.2.5 Affine Formulations Limited Recent Development
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Detail
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.3.4 Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.3.5 Aurobindo Pharma Recent Development
11.4 Biocon Limited
11.4.1 Biocon Limited Company Detail
11.4.2 Biocon Limited Business Overview
11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.4.4 Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.4.5 Biocon Limited Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.5.4 Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.6.4 Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.6.5 Cipla Recent Development
11.7 Emcure Pharmaceuticals
11.7.1 Emcure Pharmaceuticals Company Detail
11.7.2 Emcure Pharmaceuticals Business Overview
11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.7.4 Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.7.5 Emcure Pharmaceuticals Recent Development
11.8 Flamingo Pharmaceuticals Limited
11.8.1 Flamingo Pharmaceuticals Limited Company Detail
11.8.2 Flamingo Pharmaceuticals Limited Business Overview
11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.8.4 Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.8.5 Flamingo Pharmaceuticals Limited Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Detail
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.9.4 Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.9.5 Gilead Sciences Recent Development
11.10 Hetero Drugs
11.10.1 Hetero Drugs Company Detail
11.10.2 Hetero Drugs Business Overview
11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.10.4 Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.10.5 Hetero Drugs Recent Development
11.11 IPCA Laboratories
11.11.1 IPCA Laboratories Company Detail
11.11.2 IPCA Laboratories Business Overview
11.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.11.4 IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.11.5 IPCA Laboratories Recent Development
11.12 Janssen Pharmaceutica (Johnson & Johnson)
11.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Detail
11.12.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview
11.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.12.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.12.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Development
11.13 LAURUS Labs
11.13.1 LAURUS Labs Company Detail
11.13.2 LAURUS Labs Business Overview
11.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.13.4 LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.13.5 LAURUS Labs Recent Development
11.14 Medisist Pharma
11.14.1 Medisist Pharma Company Detail
11.14.2 Medisist Pharma Business Overview
11.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.14.4 Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.14.5 Medisist Pharma Recent Development
11.15 Merck
11.15.1 Merck Company Detail
11.15.2 Merck Business Overview
11.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.15.4 Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.15.5 Merck Recent Development
11.16 Mylan
11.16.1 Mylan Company Detail
11.16.2 Mylan Business Overview
11.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.16.4 Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.16.5 Mylan Recent Development
11.17 Ranbaxy Pharmaceuticals
11.17.1 Ranbaxy Pharmaceuticals Company Detail
11.17.2 Ranbaxy Pharmaceuticals Business Overview
11.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.17.4 Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.17.5 Ranbaxy Pharmaceuticals Recent Development
11.18 Shanghai Desano Pharmaceuticals
11.18.1 Shanghai Desano Pharmaceuticals Company Detail
11.18.2 Shanghai Desano Pharmaceuticals Business Overview
11.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.18.4 Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.18.5 Shanghai Desano Pharmaceuticals Recent Development
11.19 ViiV Healthcare (GSK)
11.19.1 ViiV Healthcare (GSK) Company Detail
11.19.2 ViiV Healthcare (GSK) Business Overview
11.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Introduction
11.19.4 ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
11.19.5 ViiV Healthcare (GSK) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Raltegravir
Table 3. Key Players of Elvitegravir Combination Drugs
Table 4. Key Players of Dolutegravir and Its Combination Drug
Table 5. Key Players of Bictegravir Combination Drug
Table 6. Key Players of Cabotegravir
Table 7. Key Players of Others
Table 8. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2019-2024)
Table 12. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2025-2030)
Table 14. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Trends
Table 15. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Drivers
Table 16. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Challenges
Table 17. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Restraints
Table 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players (2019-2024)
Table 20. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2023)
Table 21. Ranking of Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players HIV Integrase Strand Transfer Inhibitors (INSTI) Product Solution and Service
Table 25. Date of Enter into HIV Integrase Strand Transfer Inhibitors (INSTI) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2019-2024)
Table 29. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Type (2025-2030)
Table 31. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2019-2024)
Table 33. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2025-2030)
Table 35. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2025-2030) & (US$ Million)
Table 50. Adcock Ingram Limited Company Detail
Table 51. Adcock Ingram Limited Business Overview
Table 52. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 53. Adcock Ingram Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 54. Adcock Ingram Limited Recent Development
Table 55. Affine Formulations Limited Company Detail
Table 56. Affine Formulations Limited Business Overview
Table 57. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 58. Affine Formulations Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 59. Affine Formulations Limited Recent Development
Table 60. Aurobindo Pharma Company Detail
Table 61. Aurobindo Pharma Business Overview
Table 62. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 63. Aurobindo Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 64. Aurobindo Pharma Recent Development
Table 65. Biocon Limited Company Detail
Table 66. Biocon Limited Business Overview
Table 67. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 68. Biocon Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 69. Biocon Limited Recent Development
Table 70. Bristol-Myers Squibb Company Detail
Table 71. Bristol-Myers Squibb Business Overview
Table 72. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 73. Bristol-Myers Squibb Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 74. Bristol-Myers Squibb Recent Development
Table 75. Cipla Company Detail
Table 76. Cipla Business Overview
Table 77. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 78. Cipla Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 79. Cipla Recent Development
Table 80. Emcure Pharmaceuticals Company Detail
Table 81. Emcure Pharmaceuticals Business Overview
Table 82. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 83. Emcure Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 84. Emcure Pharmaceuticals Recent Development
Table 85. Flamingo Pharmaceuticals Limited Company Detail
Table 86. Flamingo Pharmaceuticals Limited Business Overview
Table 87. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 88. Flamingo Pharmaceuticals Limited Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 89. Flamingo Pharmaceuticals Limited Recent Development
Table 90. Gilead Sciences Company Detail
Table 91. Gilead Sciences Business Overview
Table 92. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 93. Gilead Sciences Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 94. Gilead Sciences Recent Development
Table 95. Hetero Drugs Company Detail
Table 96. Hetero Drugs Business Overview
Table 97. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 98. Hetero Drugs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 99. Hetero Drugs Recent Development
Table 100. IPCA Laboratories Company Detail
Table 101. IPCA Laboratories Business Overview
Table 102. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 103. IPCA Laboratories Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 104. IPCA Laboratories Recent Development
Table 105. Janssen Pharmaceutica (Johnson & Johnson) Company Detail
Table 106. Janssen Pharmaceutica (Johnson & Johnson) Business Overview
Table 107. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 108. Janssen Pharmaceutica (Johnson & Johnson) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 109. Janssen Pharmaceutica (Johnson & Johnson) Recent Development
Table 110. LAURUS Labs Company Detail
Table 111. LAURUS Labs Business Overview
Table 112. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 113. LAURUS Labs Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 114. LAURUS Labs Recent Development
Table 115. Medisist Pharma Company Detail
Table 116. Medisist Pharma Business Overview
Table 117. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 118. Medisist Pharma Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 119. Medisist Pharma Recent Development
Table 120. Merck Company Detail
Table 121. Merck Business Overview
Table 122. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 123. Merck Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 124. Merck Recent Development
Table 125. Mylan Company Detail
Table 126. Mylan Business Overview
Table 127. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 128. Mylan Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 129. Mylan Recent Development
Table 130. Ranbaxy Pharmaceuticals Company Detail
Table 131. Ranbaxy Pharmaceuticals Business Overview
Table 132. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 133. Ranbaxy Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 134. Ranbaxy Pharmaceuticals Recent Development
Table 135. Shanghai Desano Pharmaceuticals Company Detail
Table 136. Shanghai Desano Pharmaceuticals Business Overview
Table 137. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 138. Shanghai Desano Pharmaceuticals Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 139. Shanghai Desano Pharmaceuticals Recent Development
Table 140. ViiV Healthcare (GSK) Company Detail
Table 141. ViiV Healthcare (GSK) Business Overview
Table 142. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product
Table 143. ViiV Healthcare (GSK) Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024) & (US$ Million)
Table 144. ViiV Healthcare (GSK) Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Type: 2023 VS 2030
Figure 3. Raltegravir Features
Figure 4. Elvitegravir Combination Drugs Features
Figure 5. Dolutegravir and Its Combination Drug Features
Figure 6. Bictegravir Combination Drug Features
Figure 7. Cabotegravir Features
Figure 8. Others Features
Figure 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Application: 2023 VS 2030
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Drug Center Case Studies
Figure 14. Others Case Studies
Figure 15. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
Figure 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region: 2023 VS 2030
Figure 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Players in 2023
Figure 20. Global Top HIV Integrase Strand Transfer Inhibitors (INSTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Integrase Strand Transfer Inhibitors (INSTI) as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue in 2023
Figure 22. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2019-2030)
Figure 24. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2019-2030)
Figure 28. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Region (2019-2030)
Figure 36. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2019-2030)
Figure 44. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share by Country (2019-2030)
Figure 48. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Adcock Ingram Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 51. Affine Formulations Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 52. Aurobindo Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 53. Biocon Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 55. Cipla Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 56. Emcure Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 57. Flamingo Pharmaceuticals Limited Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 58. Gilead Sciences Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 59. Hetero Drugs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 60. IPCA Laboratories Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 61. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 62. LAURUS Labs Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 63. Medisist Pharma Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 64. Merck Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 65. Mylan Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 66. Ranbaxy Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 67. Shanghai Desano Pharmaceuticals Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 68. ViiV Healthcare (GSK) Revenue Growth Rate in HIV Integrase Strand Transfer Inhibitors (INSTI) Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}